- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Xenon Pharmaceuticals is a biotechnology business based in the US. Xenon Pharmaceuticals shares (XENE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $38.83 – an increase of 0.52% over the previous week. Xenon Pharmaceuticals employs 251 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Xenon Pharmaceuticals stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Xenon Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – XENE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Xenon Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Xenon Pharmaceuticals stock price (NASDAQ: XENE)
Use our graph to track the performance of XENE stocks over time.Xenon Pharmaceuticals shares at a glance
Information last updated 2024-12-26.
| Latest market close | $38.83 |
|---|---|
| 52-week range | $35.53 - $50.99 |
| 50-day moving average | $41.68 |
| 200-day moving average | $40.78 |
| Wall St. target price | $57.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.81 |
Is it a good time to buy Xenon Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Xenon Pharmaceuticals price performance over time
Historical closes compared with the close of $39.48 from 2024-12-26
| 1 week (2024-12-20) | 2.20% |
|---|---|
| 1 month (2024-11-27) | -8.51% |
| 3 months (2024-09-27) | 2.15% |
| 6 months (2024-06-27) | 5.53% |
| 1 year (2023-12-27) | -15.02% |
|---|---|
| 2 years (2022-12-27) | 4.72% |
| 3 years (2021-12-27) | 26.46% |
| 5 years (2019-12-27) | 195.51% |
Xenon Pharmaceuticals financials
| Gross profit TTM | $-96,333,000 |
|---|---|
| Return on assets TTM | -18.92% |
| Return on equity TTM | -26.71% |
| Profit margin | 0% |
| Book value | $12.31 |
| Market Capitalization | $2.9 billion |
TTM: trailing 12 months
Xenon Pharmaceuticals share dividends
We're not expecting Xenon Pharmaceuticals to pay a dividend over the next 12 months.
Xenon Pharmaceuticals share price volatility
Over the last 12 months, Xenon Pharmaceuticals's shares have ranged in value from as little as $35.53 up to $50.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Xenon Pharmaceuticals's is 1.251. This would suggest that Xenon Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Xenon Pharmaceuticals overview
Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1. 6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc.
Frequently asked questions
What percentage of Xenon Pharmaceuticals is owned by insiders or institutions?Currently 0.376% of Xenon Pharmaceuticals shares are held by insiders and 101.181% by institutions. How many people work for Xenon Pharmaceuticals?
Latest data suggests 251 work at Xenon Pharmaceuticals. When does the fiscal year end for Xenon Pharmaceuticals?
Xenon Pharmaceuticals's fiscal year ends in December. Where is Xenon Pharmaceuticals based?
Xenon Pharmaceuticals's address is: 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 What is Xenon Pharmaceuticals's ISIN number?
Xenon Pharmaceuticals's international securities identification number is: CA98420N1050 What is Xenon Pharmaceuticals's CUSIP number?
Xenon Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98420N105
More resources on Finder
More guides on Finder
-
Best Paper Trading Apps to Practice Trading With Fake Money in 2024
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 Best International Stock Brokers to Invest in Foreign Assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Ask a question